article thumbnail

Health literacy is a huge problem

World of DTC Marketing

University of Connecticut, 2007.). Oncologists have told us, in research, that they would like more resources to give to patients to start chemo so they better understand exactly what’s happening and what they can do to minimize side effects. economy up to $236 billion every year. Trujillo, S. Rosenbaum, and B.

article thumbnail

Innovating allergy drug delivery with a needle-free alternative

European Pharmaceutical Review

Additionally, EURneffy could alleviate the risk of accidental needle-related side effects (such as injection into the blood vessel and hand) 3 and it has the attributes of being smaller in size, has better temperature sensitivity, and is less complex to use compared to needle-based injectors. 2007; 2(1):5-11. 2022 ; 17(11).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The evolution of AAVs in cell and gene therapy

European Pharmaceutical Review

She stated that some of the key concerns were around viral safety, immunogenicity and the fact that long term side effects are unknown. Clinical Trials Information System mandatory in EU “[In] the European regulatory framework for advanced therapies, we are guided overall by REGULATION (EC) No 1394/2007,” Warner noted.

article thumbnail

Effective Pharma Ad Types & Stats

Pharma Marketing Network

This type of advertising is crucial in promoting new drugs and informing healthcare professionals about their benefits and potential side effects. ” New England Journal of Medicine, 2007. “The Effectiveness of Direct-to-Consumer Advertising in the Pharmaceutical Industry.” ” U.S.

Pharma 52
article thumbnail

Beating the Big C

Pharmaceutical Technology

Demand for treatment The American Cancer Society estimates that over 12 million new cancer cases were diagnosed worldwide in 2007. However, there’s still plenty of cancers where treatment can only prolong life by two to three months and then only with side effects that bring up serious quality of life issues.

article thumbnail

Interview: Dr Alan S Louie – US Food and Drug Administration Delays

Pharmaceutical Technology

NB: Recent figures show the pharmaceutical industry spent $168m lobbying congress in 2007, how successful were the industry’s efforts and what are the main administration issues concerning the industry at present? So far I don’t think the FDA has approved any trials evaluating stem cells in humans.